東京科学大学 統合教育機構 准教授
日本内科学会 認定内科医・総合内科専門医 日本肝臓学会 肝臓専門医・肝臓指導医・評議員・Hepatology Research Associate Editor 日本消化器病学会 消化器病専門医・消化器病指導医・学会評議員・機関誌編集委員会・ICD-11検討委員会 委員 日本消化器内視鏡学会 消化器内視鏡専門医 日本医学教育学会 会員 日本膵臓学会 会員 米国肝臓学会(AASLD) 会員 日本高齢消化器病学会 会員
続きを読む
日本内科学会 | 認定内科医・総合内科専門医 |
---|---|
日本肝臓学会 | 肝臓専門医・肝臓指導医・評議員・Hepatology Research Associate Editor |
日本消化器病学会 | 消化器病専門医・消化器病指導医・学会評議員・機関誌編集委員会・ICD-11検討委員会 委員 |
日本消化器内視鏡学会 | 消化器内視鏡専門医 |
日本医学教育学会 | 会員 |
日本膵臓学会 | 会員 |
米国肝臓学会(AASLD) | 会員 |
日本高齢消化器病学会 | 会員 |
東京科学大学病院
1996年
東京医科歯科大学 医学部
卒業
2005年
東京医科歯科大学 医学系研究科 消化器病態学 博士課程
修了
2006年
東京医科歯科大学 大学院医歯学総合研究科 寄附講座 分子肝炎制御学
助教
2010年
東京医科歯科大学 医学部附属病院 診療科 内科系診療部門 消化器内科
助教
2013年
東京医科歯科大学 学内共同教育研究施設 医歯学融合教育支援センター
准教授
2016年
東京医科歯科大学 統合教育機構
准教授
2018年
AMED肝炎等克服実用化研究事業
プログラムオフィサー
Shun Kaneko, Yasuhiro Asahina, Mina Nakagawa, Miyako Murakawa, Yasunari Miyazaki, Takahiro Asakage, Shohei Fukuda, Takeshi Namiki, Yoshito Kano, Masashi Nagata, Jun Tsuchiya, Masato Miyoshi, Fukiko Kitahata-Kawai, Sayuri Nitta, Yasuhiro Itsui, Sei Kakinuma, Ryuichi Okamoto. Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Hepatol Res. 2023.01;
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LL, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Cammà C, Bruix J, Cabibbo G, Reig M. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut. 2021.03;
Numasawa M, Nawa N, Funakoshi Y, Noritake K, Tsuruta J, Kawakami C, Nakagawa M, Yamaguchi K, Akita K. A mixed methods study on the readiness of dental, medical, and nursing students for interprofessional learning. PloS one. 2021; 16 (7): e0255086.
Nakagawa Mina, Nawa Nobutoshi, Takeichi Eiko, Shimizu Taro, Tsuchiya Jun, Sato Ayako, Miyoshi Masato, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Azuma Seishin, Kakinuma Sei, Fujiwara Takeo, Watanabe Mamoru, Tanaka Yujiro, Asahina Yasuhiro. Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs(和訳中) Journal of Gastroenterology. 2020.10; 55 (10): 990-999.
Mina Nakagawa, Nobutoshi Nawa, Eiko Takeichi, Taro Shimizu, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Takeo Fujiwara, Mamoru Watanabe, Yujiro Tanaka, Yasuhiro Asahina. Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs. J Gastroenterol. 2020.08; 55 990-999.
Nawa Nobutoshi, Numasawa Mitsuyuki, Nakagawa Mina, Sunaga Masayo, Fujiwara Takeo, Tanaka Yujiro, Kinoshita Atsuhiro. Associations between demographic factors and the academic trajectories of medical students in Japan PLoS One. 2020.05; 15 (5): e0233371.
Nitta Sayuri, Takahashi Kazuaki, Kawai-Kitahata Fukiko, Tsuchiya Jun, Sato Ayako, Miyoshi Masato, Murakawa Miyako, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Watanabe Mamoru, Asahina Yasuhiro. 慢性E型肝炎患者におけるウイルス配列および免疫グロブリン抗体価の経時変化(Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient) Hepatology Research. 2020.04; 50 (4): 524-531.
Nobutoshi Nawa, Mitsuyuki Numasawa, Mina Nakagawa, Masayo Sunaga, Takeo Fujiwara, Yujiro Tanaka, Atsuhiro Kinoshita. Differential effects of individual and school factors on the academic trajectories of Japanese dental students. Journal of dental education. 2020.03; 84 792-798.
Sato A, Kakinuma S, Miyoshi M, Kamiya A, Tsunoda T, Kaneko S, Tsuchiya J, Shimizu T, Takeichi E, Nitta S, Kawai-Kitahata F, Murakawa M, Itsui Y, Nakagawa M, Azuma S, Koshikawa N, Seiki M, Nakauchi H, Asahina Y, Watanabe M. Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts. Hepatology communications. 2020.02; 4 (2): 235-254.
Sayuri Nitta, Kazuaki Takahashi, Fukiko Kawai-Kitahata, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Miyako Murakawa, Yasuhiro Istui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe, Yasuhiro Asahina. Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient Hepatology Research. 2020; 50 (4): 524-531.
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shun Kaneko, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Tomoyuki Tsunoda, Emi Inoue-Shinomiya, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Minoru Tanabe, Emiko Sugawara, Akira Takemoto, Hidenori Ojima, Michiie Sakamoto, Masaru Muraoka, Shinichi Takano, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma. Hepatol. Res.. 2019.07;
Emi Inoue-Shinomiya, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Jun Tsuchiya, Ayako Sato, Tomoyuki Tsunoda, Masato Miyoshi, Sayuri Nitta, Fukiko Kawai-Kitahata, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Kazumoto Murata, Masashi Mizokami, Mamoru Watanabe. Association of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agents. Hepatol Res. 2019.05; 49 (5): 500-511.
Sayuri Nitta, Yasuhiro Asahina, Takanobu Kato, Jun Tsuchiya, Emi Inoue-Shinomiya, Ayako Sato, Tomoyuki Tsunoda, Masato Miyoshi, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Sei Kakinuma, Hayato Hikita, Tetsuo Takehara, Mamoru Watanabe. Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients. Sci Rep. 2019.04; 9 (1): 5722.
Tomoyuki Tsunoda, Sei Kakinuma, Masato Miyoshi, Akihide Kamiya, Shun Kaneko, Ayako Sato, Jun Tsuchiya, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Tsuyoshi Sogo, Haruki Komatsu, Ryutaro Mukouchi, Ayano Inui, Tomoo Fujisawa, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe. Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. J. Hepatol.. 2019.03;
Masato Miyoshi, Sei Kakinuma, Akihide Kamiya, Tomoyuki Tsunoda, Jun Tsuchiya, Ayako Sato, Shun Kaneko, Sayuri Nitta, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Hiromitsu Nakauchi, Yasuhiro Asahina, Mamoru Watanabe. LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Sci Rep. 2019.02; 9 (1): 2072.
Azuma S, Asahina Y, Kakinuma S, Azuma K, Miyoshi M, Inoue E, Tsunoda T, Sato A, Kaneko S, Nagata H, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Tomita M, Nakagawa M, Watanabe M. Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Digestive diseases (Basel, Switzerland). 2019; 37 (3): 247-254.
Asahina Yasuhiro, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Nakagawa Mina, Kakinuma Sei, Watanabe Mamoru. Gene Mutational Profile and Viral Integration in Hepatocellular Carcinoma with or without HBV/HCV Suppression HEPATOLOGY. 2018.10; 68 531A.
Nakagawa Mina, Asahina Yasuhiro, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Azuma Seishin, Kakinuma Sei, Tomita Makoto, Watanabe Mamoru. Post-Treatment M2BPGi Level Is Useful for Predicting HCC Occurrence and Recurrence after Viral Eradication in Chronic Hepatitis C Patients HEPATOLOGY. 2018.10; 68 398A.
Nitta Sayuri, Kato Takanobu, Tuchiya Junichi, Sato Ayako, Tsunoda Tomoyuki, Miyoshi Masato, Inoue-Shinomiya Emi, Kawai-Kitahata Fukiko, Murakawa Miyako, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Asahina Yasuhiro. The Characteristic and the Anti-HCV Reagents Susceptibility Analysis of NS5A Resistance-Associated Substitutions (RAS) Detected after Daa Treatment Failure Patients HEPATOLOGY. 2018.10; 68 600A.
Maekawa Shinya, Sato Mitsuaki, Kuratomi Natsuhiko, Inoue Taisuke, Suzuki Yuichiro, Tatsumi Akihisa, Miura Mika, Matsuda Shuya, Muraoka Masaru, Nakakuki Natsuko, Amemiya Fumitake, Takano Shinichi, Fukasawa Mitsuharu, Nakayama Yasuhiro, Yamaguchi Tatsuya, Sato Tadashi, Sakamoto Minoru, Murakawa Miyako, Nakagawa Mina, Asahina Yasuhiro, Enomoto Nobuyuki. Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C(和訳中) Journal of Gastroenterology. 2018.06; 53 (6): 780-786.
Asahina Y., Kaneko S., Kakinuma S., Kamiya A., Miyoshi M., Tsunoda T., Inoue E., Nitta S., Sato A., Nagata H., Kawai-Kitahata F., Murakawa M., Itsui Y., Nakagawa M., Azuma S., Watanabe M.. HBV reactivation and changes in interferon-stimulated gene expression during treatment of direct-acting antivirals for HCV: Analyses in a novel in vitro model for HBV-HCV coinfection using human induced pluripotent stem cell-derived hepatic cells JOURNAL OF HEPATOLOGY. 2018.04; 68 S770-S771.
Shinya Maekawa, Mitsuaki Sato, Natsuhiko Kuratomi, Taisuke Inoue, Yuichiro Suzuki, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Tadashi Sato, Minoru Sakamoto, Miyako Murakawa, Mina Nakagawa, Yasuhiro Asahina, Nobuyuki Enomoto. Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C. J. Gastroenterol.. 2017.11;
Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina. Reply to: "Imaging Basis of AFP and WFA+M2BP as Indicators of the risk of HCC after SVR". J. Hepatol.. 2017.10;
Kaneko Shun, Kakinuma Sei, Asahina Yasuhiro, Kamiya Akihide, Miyoshi Masato, Tsunoda Tomoyuki, Inoue-Shinomiya Emi, Nitta Sayuri, Sato Ayako, Asano Yu, Nagata Hiroko, Kawai-Kitahata Fukiko, Murakawa Miyako, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Watanabe Mamoru. A novel culture model for coinfection of hepatitis B and hepatitis C viruses using human induced pluripotent stem cell-derived hepatic cells for analyses of changes in host-innate immune responses HEPATOLOGY. 2017.10; 66 69A.
Murakawa Miyako, Asahina Yasuhiro, Nagata Hiroko, Nakagawa Mina, Kakinuma Sei, Nitta Sayuri, Kawai-Kitahata Fukiko, Otani Satoshi, Kaneko Shun, Miyoshi Masato, Tsunoda Tomoyuki, Asano Yu, Sato Ayako, Itsui Yasuhiro, Azuma Seishin, Nouchi Toshihiko, Furumoto Yohei, Asano Tooru, Chuganji Yoshimichi, Tohda Shuji, Watanabe Mamoru. ソホスブビル+リバビリン治療を行ったC型慢性肝炎ジェノタイプ2患者におけるITPA遺伝的変異とリバビリン誘発性貧血(ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin) Hepatology Research. 2017.10; 47 (11): 1212-1218.
Nitta Sayuri, Murakawa Miyako, Kato Takanobu, Sato Ayako, Tsunoda Tomoyuki, Miyoshi Masato, Asano Yu, Kaneko Shun, Nagata Hiroko, Kawai-Kitahata Fukiko, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Asahina Yasuhiro. The analysis of NS5A Resistance-Associated Substitutions (RAS): In vitro study of NS5A recombinant hepatitis C in infectious cell culture system for various RAS detected after treatment failure in chronic hepatitis C patients HEPATOLOGY. 2017.10; 66 480A.
Goto Fumio, Kakinuma Sei, Miyoshi Masato, Tsunoda Tomoyuki, Kaneko Shun, Sato Ayako, Asano Yu, Otani Satoshi, Azuma Seishin, Nagata Hiroko, Kawai-Kitahata Fukiko, Murakawa Miyako, Nitta Sayuri, Itsui Yasuhiro, Nakagawa Mina, Asahina Yasuhiro, Watanabe Mamoru. 骨形成因子4は胎児肝幹/前駆細胞の増殖と最終分化を調整する(Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells) Hepatology Research. 2017.08; 47 (9): 941-952.
Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Ayako Sato, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Toshihiko Nouchi, Hideki Sakai, Makoto Tomita, Mamoru Watanabe, . Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. J. Hepatol.. 2017.06;
Kentaro Matsuura, Hiromi Sawai, Kazuho Ikeo, Shintaro Ogawa, Etsuko Iio, Masanori Isogawa, Noritomo Shimada, Atsumasa Komori, Hidenori Toyoda, Takashi Kumada, Tadashi Namisaki, Hitoshi Yoshiji, Naoya Sakamoto, Mina Nakagawa, Yasuhiro Asahina, Masayuki Kurosaki, Namiki Izumi, Nobuyuki Enomoto, Atsunori Kusakabe, Eiji Kajiwara, Yoshito Itoh, Tatsuya Ide, Akihiro Tamori, Misako Matsubara, Norifumi Kawada, Ken Shirabe, Eiichi Tomita, Masao Honda, Shuichi Kaneko, Sohji Nishina, Atsushi Suetsugu, Yoichi Hiasa, Hisayoshi Watanabe, Takuya Genda, Isao Sakaida, Shuhei Nishiguchi, Koichi Takaguchi, Eiji Tanaka, Junichi Sugihara, Mitsuo Shimada, Yasuteru Kondo, Yosuke Kawai, Kaname Kojima, Masao Nagasaki, Katsushi Tokunaga, Yasuhito Tanaka, . Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. Gastroenterology. 2017.05; 152 (6): 1383-1394.
Miyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, Mina Nakagawa, Sei Kakinuma, Sayuri Nitta, Fukiko Kawai-Kitahata, Satoshi Otani, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Ayako Sato, Yasuhiro Itsui, Seishin Azuma, Toshihiko Nouchi, Yohei Furumoto, Tooru Asano, Yoshimichi Chuganji, Shuji Tohda, Mamoru Watanabe. ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatol. Res.. 2017.01;
Miyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, Mina Nakagawa, Sayuri Nitta, Satoshi Otani, Hiroko Nagata, Shun Kaneko, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Yasuhito Tanaka, Sayuki Iijima, Kaoru Tsuchiya, Namiki Izumi, Shuji Tohda, Mamoru Watanabe. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. [Epub ahead of print] J. Med. Virol.. 2016.12;
Fumio Goto, Sei Kakinuma, Masato Miyoshi, Tomoyuki Tsunoda, Shun Kaneko, Ayako Sato, Yu Asano, Satoshi Otani, Seishin Azuma, Hiroko Nagata, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Mina Nakagawa, Yasuhiro Asahina, Mamoru Watanabe. Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatol. Res.. 2016.09;
Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina, Akihide Kamiya, Masato Miyoshi, Tomoyuki Tsunoda, Sayuri Nitta, Yu Asano, Hiroko Nagata, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Hiromitsu Nakauchi, Hironori Nishitsuji, Saneyuki Ujino, Kunitada Shimotohno, Masashi Iwamoto, Koichi Watashi, Takaji Wakita, Mamoru Watanabe. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus. Sci Rep. 2016.07; 6 29358.
Hiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, Yu Asano, Tomoyuki Tsunoda, Masato Miyoshi, Shun Kaneko, Fumio Goto, Satoshi Otani, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Naoko Tojo, Shuji Tohda, Yasuhiro Asahina, Mamoru Watanabe, . Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.[Epub ahead of print] Hepatol Int. 2016.07;
Miki Taniguchi, Megumi Tasaka-Fujita, Mina Nakagawa, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Fumio Goto, Hiroko Nagata, Shun Kaneko, Sayuri Nitta, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Kenichi Mori, Shintaro Yagi, Sei Kakinuma, Yasuhiro Asahina, Mamoru Watanabe. Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System. J Clin Transl Hepatol. 2016.03; 4 (1): 5-11.
Satoshi Otani, Sei Kakinuma, Akihide Kamiya, Fumio Goto, Shun Kaneko, Masato Miyoshi, Tomoyuki Tsunoda, Yu Asano, Fukiko Kawai-Kitahata, Sayuri Nitta, Toru Nakata, Ryuichi Okamoto, Yasuhiro Itsui, Mina Nakagawa, Seishin Azuma, Yasuhiro Asahina, Tomoyuki Yamaguchi, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe. Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells. Biochem. Biophys. Res. Commun.. 2016.01; 469 (4): 1062-1068.
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto, Hiroko Nagata, Shun Kaneko, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Seishin Azuma, Yasuhiro Itsui, Mina Nakagawa, Minoru Tanabe, Shinichi Takano, Mitsuharu Fukasawa, Minoru Sakamoto, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. J. Gastroenterol.. 2015.11;
Seishin Azuma, Yasuhiro Asahina, Yuki Nishimura-Sakurai, Sei Kakinuma, Shun Kaneko, Hiroko Nagata, Fumio Goto, Satoshi Ootani, Fukiko Kawai-Kitahata, Miki Taniguchi, Miyako Murakawa, Takako Watanabe, Megumi Tasaka-Fujita, Yasuhiro Itsui, Mina Nakagawa, Mamoru Watanabe. Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma.[Epub ahead of print] Hepatol. Res. 2015.07;
Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C. J. Gastroenterol. Hepatol.. 2015.06; 30 (6): 1075-1084.
Etsuko Iio, Kentaro Matsuura, Nao Nishida, Shinya Maekawa, Nobuyuki Enomoto, Mina Nakagawa, Naoya Sakamoto, Hiroshi Yatsuhashi, Masayuki Kurosaki, Namiki Izumi, Yoichi Hiasa, Naohiko Masaki, Tatsuya Ide, Keisuke Hino, Akihiro Tamori, Masao Honda, Shuichi Kaneko, Satoshi Mochida, Hideyuki Nomura, Shuhei Nishiguchi, Chiaki Okuse, Yoshito Itoh, Hitoshi Yoshiji, Isao Sakaida, Kazuhide Yamamoto, Hisayoshi Watanabe, Shuhei Hige, Akihiro Matsumoto, Eiji Tanaka, Katsushi Tokunaga, Yasuhito Tanaka. Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C. Hum. Genet.. 2015.03; 134 (3): 279-289.
Yoshihito Kano, Sei Kakinuma, Fumio Goto, Seishin Azuma, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Mina Nakagawa, Atsushi Kudo, Minoru Tanabe, Susumu Kirimura, Tomonori Amano, Takashi Ito, Takumi Akashi, Yasuhiro Asahina, Mamoru Watanabe. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. Clin J Gastroenterol. 2014.10; 7 (5): 449-454.
Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, Ken Furuya, Mineo Kudo, Yoshimichi Chuganji, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terasita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kouji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Yasuyuki Fujita, Riichiro Abe, Miki Taniguchi, Mina Nakagawa, Yasuhiro Asahina, Naoya Sakamoto, . Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions. Hepatol Res.. 2014.09;
Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi. Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C. J. Gastroenterol. 2014.07; 49 (7): 1152-1162.
Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi. α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology. 2013.10; 58 (4): 1253-1262.
Yasuhiro Asahina, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe. Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response. J Clin Transl Hepatol. 2013.09; 1 (1): 39-44.
Kei Kiyohashi, Sei Kakinuma, Akihide Kamiya, Naoya Sakamoto, Sayuri Nitta, Hideto Yamanaka, Kouhei Yoshino, Junko Fujiki, Miyako Murakawa, Akiko Kusano-Kitazume, Hiromichi Shimizu, Ryuichi Okamoto, Seishin Azuma, Mina Nakagawa, Yasuhiro Asahina, Naoki Tanimizu, Akira Kikuchi, Hiromitsu Nakauchi, Mamoru Watanabe. Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. Hepatology. 2013.06; 57 (6): 2502-2513.
Mina Nakagawa, Naoya Sakamoto, Takako Watanabe, Yuki Nishimura-Sakurai, Izumi Onozuka, Seishin Azuma, Sei Kakinuma, Sayuri Nitta, Kei Kiyohashi, Akiko Kusano-Kitazume, Miyako Murakawa, Kohei Yoshino, Yasuhiro Itsui, Yasuhito Tanaka, Masashi Mizokami, Mamoru Watanabe, . Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C. Hepatol Int. 2013.03; 7 (1): 153-161.
Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, Naoya Sakamoto, Nobuyuki Enomoto, Kentaro Matsuura, Yasuhiro Asahina, Mina Nakagawa, Mamoru Watanabe, Minoru Sakamoto, Shinya Maekawa, Katsushi Tokunaga, Masashi Mizokami, Namiki Izumi. Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C. J. Med. Virol.. 2013.03; 85 (3): 449-458.
Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Kako Mishima, Akiko Kusano-Kitazume, Kei Kiyohashi, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Megumi Tasaka-Fujita, Yasuhiro Asahina, Mitsutoshi Yoneyama, Takashi Fujita, Mamoru Watanabe. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity. Hepatology. 2013.01; 57 (1): 46-58.
Masayuki Kurosaki, Naoki Hiramatsu, Minoru Sakamoto, Yoshiyuki Suzuki, Manabu Iwasaki, Akihiro Tamori, Kentaro Matsuura, Sei Kakinuma, Fuminaka Sugauchi, Naoya Sakamoto, Mina Nakagawa, Namiki Izumi. Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C. J. Hepatol.. 2012.03; 56 (3): 602-608.
Akiko Kusano-Kitazume, Naoya Sakamoto, Yukiko Okuno, Yuko Sekine-Osajima, Mina Nakagawa, Sei Kakinuma, Kei Kiyohashi, Sayuri Nitta, Miyako Murakawa, Seishin Azuma, Yuki Nishimura-Sakurai, Masatoshi Hagiwara, Mamoru Watanabe. Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replication. Antimicrob. Agents Chemother.. 2012.03; 56 (3): 1315-1323.
Makoto Kadokura, Shinya Maekawa, Ryota Sueki, Mika Miura, Kazuki Komase, Hiroko Shindo, Fumitake Amemiya, Tomoyoshi Uetake, Taisuke Inoue, Minoru Sakamoto, Mina Nakagawa, Naoya Sakamoto, Mamoru Watanabe, Nobuyuki Enomoto. Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy. Hepatol Int. 2011.09; 5 (3): 789-799.
Takako Watanabe, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Yasuhiro Itsui, Yuki Nishimura-Sakurai, Mayumi Ueyama, Yusuke Funaoka, Akiko Kitazume, Sayuri Nitta, Kei Kiyohashi, Miyako Murakawa, Seishin Azuma, Kiichiro Tsuchiya, Shinya Oooka, Mamoru Watanabe. Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection. Antimicrob. Agents Chemother.. 2011.06; 55 (6): 2537-2545.
Yusuke Funaoka, Naoya Sakamoto, Goki Suda, Yasuhiro Itsui, Mina Nakagawa, Sei Kakinuma, Takako Watanabe, Kako Mishima, Mayumi Ueyama, Izumi Onozuka, Sayuri Nitta, Akiko Kitazume, Kei Kiyohashi, Miyako Murakawa, Seishin Azuma, Kiichiro Tsuchiya, Mamoru Watanabe. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J. Virol.. 2011.06; 85 (12): 5986-5994.
Naoya Sakamoto, Mina Nakagawa, Yasuhito Tanaka, Yuko Sekine-Osajima, Mayumi Ueyama, Masayuki Kurosaki, Nao Nishida, Akihiro Tamori, Nishimura-Sakurai Yuki, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Shuhei Hige, Yoshito Itoh, Eiji Tanaka, Yoichi Hiasa, Namiki Izumi, Katsushi Tokunaga, Masashi Mizokami, Mamoru Watanabe, . Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b. J. Med. Virol.. 2011.05; 83 (5): 871-878.
Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, Naoya Sakamoto, Nobuyuki Enomoto, Masao Honda, Masaya Sugiyama, Kentaro Matsuura, Fuminaka Sugauchi, Yasuhiro Asahina, Mina Nakagawa, Mamoru Watanabe, Minoru Sakamoto, Shinya Maekawa, Akito Sakai, Shuichi Kaneko, Kiyoaki Ito, Naohiko Masaki, Katsushi Tokunaga, Namiki Izumi, Masashi Mizokami. Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. J. Hepatol.. 2011.03; 54 (3): 439-448.
Izumi Onozuka, Sei Kakinuma, Akihide Kamiya, Masato Miyoshi, Naoya Sakamoto, Kei Kiyohashi, Takako Watanabe, Yusuke Funaoka, Mayumi Ueyama, Mina Nakagawa, Naohiko Koshikawa, Motoharu Seiki, Hiromitsu Nakauchi, Mamoru Watanabe. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Biochem. Biophys. Res. Commun.. 2011.03; 406 (1): 134-140.
Machi Yamamoto, Naoya Sakamoto, Tetsuya Nakamura, Yasuhiro Itsui, Mina Nakagawa, Yuki Nishimura-Sakurai, Sei Kakinuma, Seishin Azuma, Kiichiro Tsuchiya, Takanobu Kato, Takaji Wakita, Mamoru Watanabe. Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture. Hepatol. Res.. 2011.03; 41 (3): 258-269.
Masayuki Kurosaki, Naoya Sakamoto, Manabu Iwasaki, Minoru Sakamoto, Yoshiyuki Suzuki, Naoki Hiramatsu, Fuminaka Sugauchi, Akihiro Tamori, Mina Nakagawa, Namiki Izumi. Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis. J. Med. Virol.. 2011.03; 83 (3): 445-452.
Makoto Kadokura, Shinya Maekawa, Ryota Sueki, Mika Miura, Kazuki Komase, Hiroko Shindo, Fumitake Amemiya, Tomoyoshi Uetake, Taisuke Inoue, Minoru Sakamoto, Mina Nakagawa, Naoya Sakamoto, Mamoru Watanabe, Nobuyuki Enomoto. Analysis of the complete open reading frame of genotype 2b hepatitis C virus in association with the response to peginterferon and ribavirin therapy. PLoS ONE. 2011.01; 6 (9): e24514.
Mayumi Ueyama, Mina Nakagawa, Naoya Sakamoto, Izumi Onozuka, Yusuke Funaoka, Takako Watanabe, Sayuri Nitta, Kei Kiyohashi, Akiko Kitazume, Miyako Murakawa, Yuki Nishimura-Sakurai, Yuko Sekine-Osajima, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Mamoru Watanabe, . Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin. Antivir. Ther. (Lond.). 2011.01; 16 (7): 1081-1091.
Goki Suda, Naoya Sakamoto, Yasuhiro Itsui, Mina Nakagawa, Megumi Tasaka-Fujita, Yusuke Funaoka, Takako Watanabe, Sayuri Nitta, Kei Kiyohashi, Seishin Azuma, Sei Kakinuma, Kiichiro Tsuchiya, Michio Imamura, Nobuhiko Hiraga, Kazuaki Chayama, Mamoru Watanabe. IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones. Virology. 2010.11; 407 (1): 80-90.
Naoya Sakamoto, Yasuhito Tanaka, Mina Nakagawa, Hiroshi Yatsuhashi, Shuhei Nishiguchi, Nobuyuki Enomoto, Seishin Azuma, Yuki Nishimura-Sakurai, Sei Kakinuma, Nao Nishida, Katsushi Tokunaga, Masao Honda, Kiyoaki Ito, Masashi Mizokami, Mamoru Watanabe. ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C. Hepatol. Res.. 2010.11; 40 (11): 1063-1071.
Kako Mishima, Naoya Sakamoto, Yuko Sekine-Osajima, Mina Nakagawa, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Kei Kiyohashi, Akiko Kitazume, Kiichiro Tsuchiya, Michio Imamura, Nobuhiko Hiraga, Kazuaki Chayama, Takaji Wakita, Mamoru Watanabe. Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants. Virology. 2010.09; 405 (2): 361-369.
Yuko Karakama, Naoya Sakamoto, Yasuhiro Itsui, Mina Nakagawa, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Sei Kakinuma, Masaya Oooka, Seishin Azuma, Kiichiro Tsuchiya, Hiroshi Onogi, Masatoshi Hagiwara, Mamoru Watanabe. Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase. Antimicrob. Agents Chemother.. 2010.08; 54 (8): 3179-3186.
Mina Nakagawa, Naoya Sakamoto, Mayumi Ueyama, Kaoru Mogushi, Satoshi Nagaie, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Hiroshi Tanaka, Nobuyuki Enomoto, Mamoru Watanabe. Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection. J. Gastroenterol.. 2010.06; 45 (6): 656-665.
Yuki Nishimura-Sakurai, Naoya Sakamoto, Kaoru Mogushi, Satoshi Nagaie, Mina Nakagawa, Yasuhiro Itsui, Megumi Tasaka-Fujita, Yuko Onuki-Karakama, Goki Suda, Kako Mishima, Machi Yamamoto, Mayumi Ueyama, Yusuke Funaoka, Takako Watanabe, Seishin Azuma, Yuko Sekine-Osajima, Sei Kakinuma, Kiichiro Tsuchiya, Nobuyuki Enomoto, Hiroshi Tanaka, Mamoru Watanabe. Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J. Gastroenterol.. 2010.05; 45 (5): 523-536.
Yasuhiro Itsui, Naoya Sakamoto, Sei Kakinuma, Mina Nakagawa, Yuko Sekine-Osajima, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Gouki Suda, Yuko Karakama, Kako Mishima, Machi Yamamoto, Takako Watanabe, Mayumi Ueyama, Yusuke Funaoka, Seishin Azuma, Mamoru Watanabe. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology. 2009.12; 50 (6): 1727-1737.
Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama, Masayuki Kurosaki, Kentaro Matsuura, Naoya Sakamoto, Mina Nakagawa, Masaaki Korenaga, Keisuke Hino, Shuhei Hige, Yoshito Ito, Eiji Mita, Eiji Tanaka, Satoshi Mochida, Yoshikazu Murawaki, Masao Honda, Akito Sakai, Yoichi Hiasa, Shuhei Nishiguchi, Asako Koike, Isao Sakaida, Masatoshi Imamura, Kiyoaki Ito, Koji Yano, Naohiko Masaki, Fuminaka Sugauchi, Namiki Izumi, Katsushi Tokunaga, Masashi Mizokami. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet.. 2009.10; 41 (10): 1105-1109.
Yuko Sekine-Osajima, Naoya Sakamoto, Mina Nakagawa, Yasuhiro Itsui, Megumi Tasaka, Yuki Nishimura-Sakurai, Cheng-Hsin Chen, Goki Suda, Kako Mishima, Yuko Onuki, Machi Yamamoto, Shinya Maekawa, Nobuyuki Enomoto, Takanori Kanai, Kiichiro Tsuchiya, Mamoru Watanabe. Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. Hepatol. Res.. 2009.01; 39 (1): 60-69.
Naoya Sakamoto, Yoko Tanabe, Takanori Yokota, Kenichi Satoh, Yuko Sekine-Osajima, Mina Nakagawa, Yasuhiro Itsui, Megumi Tasaka, Yuki Sakurai, Chen Cheng-Hsin, Masahiko Yano, Shogo Ohkoshi, Yutaka Aoyagi, Shinya Maekawa, Nobuyuki Enomoto, Michinori Kohara, Mamoru Watanabe. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA. J. Gastroenterol. Hepatol.. 2008.09; 23 (9): 1437-1447.
Yuko Sekine-Osajima, Naoya Sakamoto, Kako Mishima, Mina Nakagawa, Yasuhiro Itsui, Megumi Tasaka, Yuki Nishimura-Sakurai, Cheng-Hsin Chen, Takanori Kanai, Kiichiro Tsuchiya, Takaji Wakita, Nobuyuki Enomoto, Mamoru Watanabe. Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity. Virology. 2008.02; 371 (1): 71-85.
Megumi Tasaka, Naoya Sakamoto, Yoshie Itakura, Mina Nakagawa, Yasuhiro Itsui, Yuko Sekine-Osajima, Yuki Nishimura-Sakurai, Cheng-Hsin Chen, Mitsutoshi Yoneyama, Takashi Fujita, Takaji Wakita, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. J. Gen. Virol.. 2007.12; 88 (Pt 12): 3323-3333.
Tsuyoshi Yamashiro, Naoya Sakamoto, Masayuki Kurosaki, Nobuhiko Kanazawa, Yoko Tanabe, Mina Nakagawa, Cheng-Hsin Chen, Yasuhiro Itsui, Tomoyuki Koyama, Yoshie Takeda, Shinya Maekawa, Nobuyuki Enomoto, Hiroshi Sakugawa, Mamoru Watanabe. Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3. J. Gastroenterol.. 2006.08; 41 (8): 750-757.
Tomoyuki Koyama, Naoya Sakamoto, Yoko Tanabe, Mina Nakagawa, Yasuhiro Itsui, Yoshie Takeda, Sei Kakinuma, Yuko Sekine, Shinya Maekawa, Yoshiaki Yanai, Masashi Kurimoto, Mamoru Watanabe. Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication. Hepatol. Res.. 2006.01; 34 (1): 41-49.
Mina Nakagawa, Naoya Sakamoto, Yoko Tanabe, Tomoyuki Koyama, Yasuhiro Itsui, Yoshie Takeda, Cheng-Hsin Chen, Sei Kakinuma, Shinya Oooka, Shinya Maekawa, Nobuyuki Enomoto, Mamoru Watanabe. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Gastroenterology. 2005.09; 129 (3): 1031-1041.
Nobuhiko Kanazawa, Masayuki Kurosaki, Naoya Sakamoto, Nobuyuki Enomoto, Yasuhiro Itsui, Tsuyoshi Yamashiro, Yoko Tanabe, Shinya Maekawa, Mina Nakagawa, Cheng-Hsin Chen, Sei Kakinuma, Shigeru Oshima, Tetsuya Nakamura, Takanobu Kato, Takaji Wakita, Mamoru Watanabe. Regulation of hepatitis C virus replication by interferon regulatory factor 1. J. Virol.. 2004.09; 78 (18): 9713-9720.
Yoko Tanabe, Naoya Sakamoto, Nobuyuki Enomoto, Masayuki Kurosaki, Eri Ueda, Shinya Maekawa, Tsuyoshi Yamashiro, Mina Nakagawa, Cheng-Hsin Chen, Nobuhiko Kanazawa, Sei Kakinuma, Mamoru Watanabe. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. J. Infect. Dis.. 2004.04; 189 (7): 1129-1139.
Mina Nakagawa, Naoya Sakamoto, Nobuyuki Enomoto, Yoko Tanabe, Nobuhiko Kanazawa, Tomoyuki Koyama, Masayuki Kurosaki, Shinya Maekawa, Tsuyoshi Yamashiro, Cheng Hsin Chen, Yasuhiro Itsui, Sei Kakinuma, Mamoru Watanabe. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem. Biophys. Res. Commun.. 2004.01; 313 (1): 42-47.
Junichi Tazawa, Manabu Maeda, Mina Nakagawa, Hideo Ohbayashi, Fumihiko Kusano, Michio Yamane, Yoshinori Sakai, Keiko Suzuki. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig. Dis. Sci.. 2002.04; 47 (4): 710-715.
Nakagawa Mina, Asahina Yasuhiro, Kakinuma Sei, Okamoto Ryuichi. Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR JOURNAL OF GASTROENTEROLOGY. 2022.12;
中川 美奈, 朝比奈 靖浩. 【ウイルス肝炎Annual Update】C型肝炎 C型肝炎SVR後の生命予後 肝胆膵. 2022.07; 85 (1): 49-57.
大科 枝里, 小林 正典, 金城 美幸, 中川 美奈, 大塚 和朗, 赤星 径一, 田邉 稔, 松木 裕子, 小林 大輔, 岡本 隆一. 胆道閉鎖症に対して胆嚢十二指腸吻合術後52年で胆管癌を発症し切除しえた1例 日本消化器病学会雑誌. 2022.07; 119 (7): 683-691.
Ohshina E, Kobayashi M, Kaneshiro M, Nakagawa M, Ohtsuka K, Akahoshi K, Tanabe M, Matsuki Y, Kobayashi D, Okamoto R. [A curatively resectable case of cholangiocarcinoma 52 years after cholecystoduodenostomy for biliary atresia]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 2022; 119 (7): 683-691.
中川美奈. SVR後の発癌と生命予後 消化器・肝臓内科. 2021.12; 10 (6): 724-731.
那波 伸敏, 沼沢 益行, 中川 美奈, 須永 昌代, 木下 淳博, 山口 久美子, 秋田 恵一, 鹿島田 彩子, 井津井 康浩, 岡田 英理子, 山脇 正永. 医学教育プログラム評価の理論と実践〜教学IRの組織的な取組みの視点から〜 医学教育プログラム評価の理論と実践 東京医科歯科大学における取り組み 教学IRスタッフの視点から 医学教育. 2021.07; 52 (Suppl.): 63.
井津井 康浩, 那波 伸敏, 沼沢 益行, 舟越 優, 鹿島田 彩子, 山口 久美子, 岡田 英理子, 中川 美奈, 山脇 正永. 医学科学生に対する地域医療実習がもたらす専門職連携教育効果の解析 医学教育. 2021.07; 52 (Suppl.): 180.
中川 美奈, 朝比奈 靖浩. 【いまさら聞けない! 肝胆膵疾患-みなさんのギモンに答えます】肝機能異常をみたら B型肝炎・C型肝炎治療薬による治療中の副作用と治療終了後の留意点 Medicina. 2021.03; 58 (3): 420-423.
中川 美奈, 村川 美也子, 朝比奈 靖浩. ウイルス肝炎診療:新旧の課題と解決への戦略 C型慢性肝疾患SVR後肝発癌の検討 肝臓. 2020.11; 61 (Suppl.3): A777.
中川美奈. SVR後C型慢性肝疾患での拾い上げ 消化器・肝臓内科. 2020.09; 8 (4): 387-393.
中川美奈、朝比奈靖浩. 核酸アナログ投与下の合併症 消化器・肝臓内科. 2020.08; 8 (2): 171-177.
Murakawa Miyako, Shimizu Taro, Takeichi Eiko, Tsuchiya Jun, Sato Ayako, Miyoshi Masato, Kawai-Kitahata Fukiko, Nitta Sayuri, Itsui Yasuhiro, Nakagawa Mina, Azuma Seishin, Kakinuma Sei, Asahina Yasuhiro. Poor improvement of on-treatment FIB-4 index after initiation of nucleos(t)ide analogs is associated with development of hepatocellular carcinoma in both cirrhotic and non-cirrhotic chronic hepatitis B patients JOURNAL OF HEPATOLOGY. 2020.08; 73 S592-S593.
中川美奈. C型慢性肝疾患におけるSVR後肝発癌予測因子の検討 肝胆膵. 2020.07; 81 (1): 99-106.
中川美奈. DAA治療後の発癌と生命予後 消化器・肝臓内科. 2020.07; 8 (1): 81-87.
中川 美奈, 村川 美也子, 朝比奈 靖浩. C型肝炎SVR後の諸問題とその対策 C型慢性肝疾患SVR後肝発癌予測因子の検討 日本消化器病学会雑誌. 2020.07; 117 (臨増総会): A145.
中川 美奈. 【2020年のC型肝炎-Total CureとPost SVR-】肝発癌 C型慢性肝疾患におけるSVR後肝発癌予測因子の検討 肝胆膵. 2020.07; 81 (1): 99-106.
中川美奈、村川美也子、朝比奈靖浩. Post SVRにおけるM2BPGiの意義 肝胆膵. 2019.04; 78 (4): 604-614.
中川 美奈, 村川 美也子, 朝比奈 靖浩. 【Post SVR時代のC型肝炎診療】Post SVRの諸問題 Post SVRにおけるM2BPGiの意義 肝胆膵. 2019.04; 78 (4): 607-614.
中川美奈. 肝疾患患者の生活指導 今日の治療指針 2019年版. 2019.01; 583-584.
中川美奈. 腫瘍マーカーと線維化・発がんリスクマーカー 最新医学別冊 診断と治療のABC. 2019.01; 80-87.
中川 美奈. 【診断と治療のABC[142]ウイルス性肝炎】(第3章)診断 腫瘍マーカーと線維化・発がんリスクマーカー 最新医学. 2019.01; 別冊 (ウイルス性肝炎): 80-87.
中川 美奈, 村川 美也子, 朝比奈 靖浩. B型、C型ウイルス肝炎治療をまとめる 肝発癌の完全制御を目指したC型慢性肝疾患SVR後サーベイランスの検討 肝臓. 2018.11; 59 (Suppl.3): A785.
井津井 康浩, 北畑 富貴子, 新田 沙由梨, 村川 美也子, 中川 美奈, 東 正新, 柿沼 晴, 朝比奈 靖浩, 渡辺 守. 免疫抑制状態によるE型肝炎慢性化症例の解析 肝臓. 2018.11; 59 (Suppl.3): A958.
C型慢性肝疾患におけるSVR後肝発癌を硬さから推定する 肝臓クリニカルアップデート. 2018.10; 4 (2):
中川 美奈. 【肝臓の"硬さ"を診療に生かす】 C型慢性肝疾患におけるSVR後肝発癌を硬さから推定する 肝臓クリニカルアップデート. 2018.10; 4 (2): 161-166.
中川 美奈, 朝比奈 靖浩, 渡辺 守. HCV関連肝癌の完全制御を目指したC型肝炎の基礎と臨床 HCVウイルスおよび宿主変異がDAA治療後肝発癌に与える影響 肝臓. 2018.09; 59 (Suppl.2): A593.
川上 千春, 山口 久美子, 中川 美奈, 市川 理子, 吉橋 洋子, 鶴田 潤, 高田 和生. 専門職連携教育を通して看護学生がとらえた社会福祉士の専門性と影響 医学教育. 2018.07; 49 (Suppl.): 183.
山口 久美子, 中川 美奈, 市川 理子, 吉橋 洋子, 川上 千春, 則武 加奈子, 鶴田 潤, 高田 和生. 多職種チームに福祉職が入ることによるチームの意志決定への影響について 医学教育. 2018.07; 49 (Suppl.): 182.
岡田 英理子, 高橋 誠, 井津井 康浩, 中川 美奈, 山口 久美子, 金子 英司, 角 勇樹, 田中 雄二郎. 1年生の症候学導入講義に関する有用性の報告(第3報) 医学教育. 2018.07; 49 (Suppl.): 187.
中川 美奈, 朝比奈 靖浩. 【消化器疾患における性差医療を考える】 肝炎ウイルスと性差 消化器・肝臓内科. 2018.05; 3 (5): 529-536.
中川 美奈, 朝比奈 靖浩, 渡辺 守. C型肝炎〜完全制圧を目指した治療戦略〜 DAA治療後の耐性ウイルス出現と肝発癌の完全制御を目指した治療戦略 肝臓. 2018.04; 59 (Suppl.1): A137.
新田 沙由梨, 朝比奈 靖浩, 佐藤 綾子, 三好 正人, 角田 知之, 永田 紘子, 金子 俊, 北畑 富貴子, 村川 美也子, 中川 美奈, 東 正新, 柿沼 晴, 加藤 孝宣, 渡辺 守. HCV NS5Aキメラ株感染培養系を用いたNS5A阻害剤に対する耐性変異と薬剤感受性評価システムの構築 肝臓. 2018.04; 59 (Suppl.1): A318.
中川美奈, 永田紘子, 朝比奈靖浩. DAA治療による肝発癌・再発抑制効果—自験例からー 肝胆膵. 2018.02; 76 (2): 277-284.
中川 美奈, 永田 紘子, 朝比奈 靖浩. 【C型肝炎の新たな壁を越える次世代DAA治療】 Post SVRの課題と克服への展望 DAA治療による肝発癌・再発抑制効果 自験例から 肝・胆・膵. 2018.02; 76 (2): 277-284.
中川美奈、永田紘子、朝比奈靖浩. 【特集: C型肝炎の新たな壁を越える次世代DAA治療】DAA治療による肝発癌・再発抑制効果-自験例から- 肝胆膵. 2018.02; 76 (2): 277-284.
中川美奈、朝比奈靖浩. 【ここまで変わったC型肝炎の治療】 DAA治療のアウトカム 肝予備能、肝外臓器およびQOLへの影響 最新医学. 2017.09; 72 (9): 1291-1301.
山下 萌, 永田 紘子, 金子 俊, 井津井 康浩, 東 正新, 中川 美奈, 朝比奈 靖浩, 渡辺 守, 赤星 径一, 松山 貴俊. 胆嚢十二指腸瘻に伴う胆石小腸内嵌頓による胆石イレウスの1例 日本内科学会関東地方会. 2017.09; 635回 35.
永田 紘子, 中川 美奈, 朝比奈 靖浩. C型肝炎SVR例の予後改善 C型慢性肝炎に対するIFN-based、IFN-free治療SVR後発癌および発癌予測因子についての検討 日本消化器病学会雑誌. 2017.09; 114 (臨増大会): A636.
中川 美奈, 朝比奈 靖浩, 渡辺 守. SVR100%を目指すDAAs治療 C型慢性肝疾患に対するインターフェロンフリー治療不成功および治療後発癌例の検討 肝臓. 2017.09; 58 (Suppl.2): A518.
中川 美奈, 山口 久美子, 高田 和生, 北川 昌伸, 田中 雄二郎. DREEM質問票を用いた医学部学生の学習環境調査の試み 医学教育. 2017.08; 48 (Suppl.): 122.
岡田 英理子, 高橋 誠, 井津井 康浩, 中川 美奈, 山口 久美子, 金子 英司, 角 勇樹, 田中 雄二郎. 症候学入門講義のpost-test導入による改善と課題 医学教育. 2017.08; 48 (Suppl.): 86.
市川 理子, 中川 美奈, 山口 久美子, 吉橋 洋子, 鶴田 潤, 川上 千春, 高田 和生. 日本の単施設における専門職連携の阻害要因調査と卒前専門職連携教育到達目標の再設定 医学教育. 2017.08; 48 (Suppl.): 129.
山口 久美子, 中川 美奈, 川上 千春, 市川 理子, 吉橋 洋子, 鶴田 潤, 高田 和生. 専門職連携プログラムにおける患者中心の医療への視点の変化 医学教育. 2017.08; 48 (Suppl.): 232.
柿沼 晴, 浅野 侑, 三好 正人, 佐藤 綾子, 角田 知之, 金子 俊, 大谷 賢志, 永田 紘子, 北畑 富貴子, 村川 美也子, 新田 沙由梨, 井津井 康浩, 中川 美奈, 東 正新, 朝比奈 靖浩, 渡辺 守. 食餌誘導性NASHモデルマウスにおけるMatrix metalloproteinase-2の機能的解析 肝臓. 2017.04; 58 (Suppl.1): A449.
永田 紘子, 中川 美奈, 朝比奈 靖浩. C型肝炎SVR後の問題点 C型慢性肝炎に対するIFN-based、IFN-free治療後発癌および発癌予測因子についての検討 肝臓. 2017.04; 58 (Suppl.1): A118.
中川 美奈, 朝比奈 靖浩, 渡辺 守. C型肝炎インターフェロンフリー治療の現況 C型慢性肝疾患に対するインターフェロンフリー治療の有効性の検討 日本消化器病学会雑誌. 2017.03; 114 (臨増総会): A131.
武市瑛子、柿沼 晴、大谷賢志、小橋健一郎、東 正新、北畑富貴子、村川美也子、櫻井 幸、新田沙由梨、井津井康浩、中川美奈、朝比奈靖浩、渡辺 守. Direct-acting antiviralsによる抗ウイルス療法が著効し、C型肝炎ウイルス関連クリオグロブリン腎症が改善した一例 肝臓. 2016.08; 57 (8): 405-411.
中川美奈、朝比奈靖浩、村川美也子、永田紘子、金子 俊、大谷賢志、北畑富貴子、新田沙由梨、櫻井 幸、井津井康浩、東 正新、柿沼 晴、今田安津子、伊藤 崇、谷合麻紀子、橋本悦子、田中雄二郎、渡辺 守. 5年にわたる経時的な経過観察の中で急激なエコー上変化をきたした原発性硬化性胆管炎の1例 肝臓. 2016.08; 57 (8): 382-390.
土谷 薫, 中川 美奈, 谷合 麻紀子, 飯島 尋子, 岡 博子, 島田 光生, 高原 照美, 滝川 康裕, 田中 純子, 田中 靖人, 中牟田 誠, 名越 澄子, 長谷部 千登美, 高山 忠利, 橋本 悦子, 日本肝臓学会男女共同参画委員会. 日本肝臓学会男女共同参画委員会アンケート調査報告 肝臓. 2016.04; 57 (4): 194-200.
中川美奈、朝比奈靖浩. 【新ウイルス性肝炎学 -最新の基礎・臨床研究情報-】特論2:C型肝炎IFN治療後の線維化マーカーと発癌リスク 日本臨床. 2015.12; (1090): 668-673.
Mina Nakagawa, Yasuhiro Asahina. [Prognostic significance of fibrosis markers in hepatocellular carcinoma among patients with IFN-based therapy]. Nippon Rinsho. 2015.12; 73 Suppl 9 668-673.
中川 美奈, 朝比奈 靖浩. 【いまB型・C型肝炎をどう治療するか】 【C型肝炎】プロテアーゼ阻害剤3剤併用療法の効果と注意点 消化器の臨床. 2015.02; 18 (1): 66-73.
櫻井 幸, 朝比奈 靖浩, 宍戸 華子, 井津井 康浩, 中川 美奈, 柿沼 晴, 東 正新, 東條 尚子, 渡辺 守. 多彩な超音波画像の変化を呈した原発性硬化性胆管炎の一例 超音波医学. 2014.04; 41 (Suppl.): S543.
Yuko Sekine-Osajima, Mina Nakagawa, Naoya Sakamoto. [Mechanism of hepatitis C virus (HCV) RNA replication and HCV genetic variability]. Nippon Rinsho. 2011.05; 69 Suppl 4 52-58.
Nobuhiko Kanazawa, Mina Nakagawa, Hideki Watanabe, Naoya Sakamoto, Nobuyuki Enomoto. [Virus factors determining the outcome of IFN treatment for chronic hepatitis C]. Nippon Rinsho. 2004.07; 62 Suppl 7 (Pt 1): 474-480.
Mina Nakagawa, Nobuyuki Enomoto, Naoya Sakamoto. [Hepatitis C virus infection]. Nippon Rinsho. 2003.03; 61 Suppl 3 627-633.
本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。
なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。